ABVX
Abivax S.A.
94.90$
+0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +177.6% | -125.7% | – | -23.7% | +12.7% | -17.5% | +357.6% | +60.6% | +45.8% | +55.6% | -6.4% | |
| – | – | – | – | – | – | – | – | -240.6% | – | +147.3% | +75.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +95.3% | -24.3% | +116.7% | -14.4% | +48.8% | +37.9% | -106.9% | – | – | -93.3% | +146.5% | |
| – | +2,273.5% | -29.7% | +35.8% | -22.1% | +23.3% | -4.6% | -94.8% | +587.2% | -18.0% | +142.6% | -78.8% | |
| – | +2,262.8% | -90.7% | +11.7% | +141.9% | +45.7% | +55.4% | +983.8% | +93.0% | -12.7% | – | -183.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +115.0% | -18.7% | -151.2% | – | +146.0% | -258.8% | |
| – | +777.3% | -100.8% | – | +316.6% | +127.3% | +102.9% | +65.6% | -61.0% | +957.3% | -91.7% | +1,785.8% | |
| – | +1,156.7% | -144.6% | – | – | – | – | +60.8% | -207.5% | – | -147.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.